OM insider transaction filings
Outset Medical, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen OM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 3,437 @ $4.39 | EDGAR |
| 2026-08-18 | 4 | Brottem John L. — General Counsel | Sale (S): 2,632 @ $4.39 | EDGAR |
| 2026-08-18 | 4 | Gaeta Renee — Chief Financial Officer | Sale (S): 4,543 @ $4.39 | EDGAR |
| 2026-06-29 | 4 | Brottem John L. — General Counsel | Grant/award (A): 59,830 @ $0 | EDGAR |
| 2026-06-29 | 4 | Gaeta Renee — Chief Financial Officer | Grant/award (A): 71,630 @ $0 | EDGAR |
| 2026-06-29 | 4 | Trigg Leslie — Chair and CEO, Director | Grant/award (A): 99,160 @ $0 | EDGAR |
| 2026-06-05 | 4 | Prange Karen — Director | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-06-05 | 4 | LANG BRENT D. — Director | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-06-05 | 4 | Drexler Karen — Director | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-06-05 | 4 | Gaeta Renee — Chief Financial Officer | Sale (S): 17,672 @ $4.94 | EDGAR |
| 2026-06-05 | 4 | HACKETT PATRICK T — Director | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-06-05 | 4 | GROSSMAN D KEITH — Director | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-06-05 | 4 | OBOYLE KEVIN C — Director | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-05-19 | 4 | Nash Marc — EVP Operations R&D & Service | Sale (S): 1,582 @ $3.70 | EDGAR |
| 2026-05-19 | 4 | Brottem John L. — General Counsel | Sale (S): 2,638 @ $3.70 | EDGAR |
| 2026-05-19 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 3,445 @ $3.70 | EDGAR |
| 2026-05-18 | 4 | Leonard Braden Michael — 10% owner | Option exercise/expiry (X): 323,000 @ $5 | EDGAR |
| 2026-05-12 | 4 | Leonard Braden Michael — 10% owner | Option exercise/expiry (X): 197,600 @ $5 · Option exercise/expiry (X): 96,900 @ $5 | EDGAR |
| 2026-04-08 | 4 | Elliott Derick A. — EVP, Commercial | Grant/award (A): 96,000 @ $0 | EDGAR |
| 2026-02-19 | 4 | Nash Marc — EVP Operations R&D & Service | Sale (S): 1,817 @ $3.35 | EDGAR |
| 2026-02-19 | 4 | Brottem John L. — General Counsel | Sale (S): 2,842 @ $3.35 | EDGAR |
| 2026-02-19 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 3,361 @ $3.35 | EDGAR |
| 2026-01-21 | 4 | Nash Marc — EVP Operations R&D & Service | Sale (S): 5,375 @ $5.12 · Sale (S): 980 @ $4.98 | EDGAR |
| 2026-01-21 | 4 | Brottem John L. — General Counsel | Sale (S): 9,314 @ $5.12 · Sale (S): 1,180 @ $5.01 | EDGAR |
| 2026-01-21 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 11,794 @ $5.12 · Sale (S): 2,120 @ $5.05 | EDGAR |
| 2026-01-12 | 4 | Prange Karen — Director | Grant/award (A): 18,667 @ $0 | EDGAR |
| 2026-01-08 | 4 | Nash Marc — EVP Operations R&D & Service | Sale (S): 108 @ $4.27 | EDGAR |
| 2026-01-08 | 4 | Brottem John L. — General Counsel | Sale (S): 224 @ $4.27 | EDGAR |
| 2026-01-08 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 1,795 @ $4.27 | EDGAR |
| 2025-12-02 | 4 | Drexler Karen — Director | Sale (S): 1,548 @ $4.37 | EDGAR |
| 2025-11-18 | 4 | Nash Marc — EVP Operations R&D & Service | Sale (S): 247 @ $4.60 | EDGAR |
| 2025-11-18 | 4 | Brottem John L. — General Counsel | Sale (S): 388 @ $4.60 | EDGAR |
| 2025-11-18 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 916 @ $4.60 | EDGAR |
| 2025-08-25 | 4 | Nash Marc — EVP, R&D, Operations and Serv. | Grant/award (A): 5,617 @ $0 | EDGAR |
| 2025-08-18 | 4 | Nash Marc — SVP Operations and R&D | Sale (S): 243 @ $12.88 | EDGAR |
| 2025-08-18 | 4 | Brottem John L. — General Counsel | Sale (S): 383 @ $12.88 | EDGAR |
| 2025-08-18 | 4 | Trigg Leslie — Chair and CEO, Director | Sale (S): 904 @ $12.88 | EDGAR |
| 2025-06-11 | 4 | Nash Marc — SVP Operations and R&D | Grant/award (A): 29,676 @ $0 | EDGAR |
| 2025-06-11 | 4 | Brottem John L. — General Counsel | Grant/award (A): 35,993 @ $0 | EDGAR |
| 2025-06-11 | 4 | Gaeta Renee — Chief Financial Officer | Grant/award (A): 131,425 @ $0 | EDGAR |
| 2025-06-11 | 4 | Trigg Leslie — Chair and CEO, Director | Grant/award (A): 65,103 @ $0 | EDGAR |
| 2025-06-04 | 4 | Saia Andrea Lynn — Director | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-06-04 | 4 | LANG BRENT D. — Director | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-06-04 | 4 | Drexler Karen — Director | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-06-04 | 4 | HACKETT PATRICK T — Director | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-06-04 | 4 | GROSSMAN D KEITH — Director | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-06-04 | 4 | OBOYLE KEVIN C — Director | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-05-16 | 4 | Nash Marc — SVP Operations and R&D | Sale (S): 252 @ $17.82 | EDGAR |
| 2025-05-16 | 4 | Brottem John L. — General Counsel | Sale (S): 396 @ $17.82 | EDGAR |
| 2025-05-16 | 4 | Ahmed Nabeel — Chief Financial Officer | Sale (S): 584 @ $17.81 | EDGAR |
Recent 8-K events — Outset Medical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →